Product Description

MAP2K2 Monoclonal Antibody

Sizes: 50μL, 100μL

Catalogue Number: BT-MCA3313-50, BT-MCA3313-100

Citations, Manuals and MSDS Available upon request.

Background: MAP2K2, also called MEK2, it is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax.

Research Areas: Signal transduction, Cancer

Target Protein: MAP2K2

Applications: WB, ICC, FCM

Reactivity: Human, Mouse, Rat

Clonality: Monoclonal

Clone ID: 7F5

Host: Mouse

Isotype: Mouse IgG1

Full Product Name: MAP2K2

Immunogen: Purified recombinant fragment of human MAP2K2 expressed in E. Coli.

Storage: 4°C|-20°C for long term storage

Formulation: Ascitic fluid containing 0.03% sodium azide.

Molecular Weight (Da): 44kDa

UniProt Accession: P36507

Synonyms: MEK2, MKK2, MAPKK2

GeneID: 5605

Research Use Only